Alzheimer’s Therapeutics Market
Alzheimer’s Therapeutics Market Scope: Industry
Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Alzheimer’s Therapeutics Market Size and Growth
The Alzheimer's Therapeutics market is expected to grow steadily due to the increasing prevalence of Alzheimer's disease worldwide. The market size is projected to reach USD 7.5 billion by 2025, driven by advancements in drug development and rising healthcare expenditure. Key players include Biogen, Roche, and Novartis.
Companies Covered
(Covid 19 Impact Covered)
◍ Pfizer
◍ Merck &
◍ Novartis AG
◍ Eisai
◍ H. Lundbeck A/S
◍ AC Immune
◍ TauRx Pharmaceuticals
◍ Actavis plc.
◍ Forest Laboratories
◍ Teva Pharmaceuticals Industries
◍ Janssen Pharmaceutical
◍ GE healthcare
◍ Eli Lilly And Company
◍ DiaGenic ASA
◍ VTV Therapeutics
◍ Hoffman-La Roche
◍ AstraZeneca
◍ Daiichi Sankyo Company
The competitive landscape of Alzheimer’s Therapeutics Market includes key players such as Pfizer, Merck & Co., Novartis AG, Eisai, H. Lundbeck A/S, AC Immune, TauRx Pharmaceuticals, Actavis plc., Forest Laboratories, Teva Pharmaceuticals Industries, Janssen Pharmaceutical, GE healthcare, Eli Lilly And Company, DiaGenic ASA, VTV Therapeutics, Hoffman-La Roche, AstraZeneca, and Daiichi Sankyo Company. These companies develop and market therapeutics for Alzheimer’s disease, contributing to the growth of the market.
- Pfizer reported sales revenue of $51.75 billion in 2020.
- Merck & Co. reported sales revenue of $47.99 billion in 2020.
- Novartis AG reported sales revenue of $48.70 billion in 2020.
Request Sample Report
Market Segmentation
By Application
Early to Moderate Stages ◍ Moderate to Severe Stages
By Product
Donepezil
Memantine
Rivastigmine
Request Sample Report
Market Growth
Request Sample Report
$ X Billion USD
